With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma||University of California San Francisco / William Clay Gustafson, MD, PhD||'A' Award Grants||2011||California|
|A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG)||Stanford University / Michelle Monje, MD, PhD||'A' Award Grants||2011||California|
|SickKids MIBG and Phase I Leukemia Programs||Hospital for Sick Children / James Whitlock, MD||Phase I/II Infrastructure Grants||2011||Ontario|
|Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant||University of Pittsburgh / A. Kim Ritchey||Phase I/II Infrastructure Grants||2011||Pennsylvania|
|Phase I and II Clinical Research Program Infrastructure Award||University of Minnesota / Brenda Weigel, MD, MSc||Phase I/II Infrastructure Grants||2011||Minnesota|
|Development of a Childhood Leukemia Translational Research Program||Dana-Farber Cancer Institute / Lewis Silverman||Phase I/II Infrastructure Grants||2011||Massachusetts|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|
|Studying the clonal dynamics and evolution of leukemia using molecular barcodes||Lucile Packard Children's Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD||Innovation Grants||2011||California|
|Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma||University of California, San Diego / Alice Yu, MD, PhD||Innovation Grants||2011||California|
|Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells||Baylor College of Medicine / Jason Shohet, MD, PhD||Innovation Grants||2011||Texas|